5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine

C103H111Cl5N18O2S2 — CID 159692163

IUPAC5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine
SMILESCCCCS(=O)(=O)n1cc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)cn1.Clc1cc(Cl)cc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)c1.Clc1ccc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)cc1Cl.Clc1ccc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)s1
InChIInChI=1S/C27H34N6O2S.2C26H26Cl2N4.C24H25ClN4S/c1-2-3-18-36(34,35)32-21-24(20-28-32)25-9-6-10-27-29-26(30-33(25)27)19-23-13-11-22(12-14-23)8-7-17-31-15-4-5-16-31;27-22-13-12-21(18-23(22)28)24-6-3-7-26-29-25(30-32(24)26)17-20-10-8-19(9-11-20)5-4-16-31-14-1-2-15-31;27-22-16-21(17-23(28)18-22)24-6-3-7-26-29-25(30-32(24)26)15-20-10-8-19(9-11-20)5-4-14-31-12-1-2-13-31;25-22-13-12-21(30-22)20-6-3-7-24-26-23(27-29(20)24)17-19-10-8-18(9-11-19)5-4-16-28-14-1-2-15-28/h6,9-14,20-21H,2-5,7-8,15-19H2,1H3;3,6-13,18H,1-2,4-5,14-17H2;3,6-11,16-18H,1-2,4-5,12-15H2;3,6-13H,1-2,4-5,14-17H2
InChIKeyMWOBCMCZRDVOLW-UHFFFAOYSA-N
MW1874.54 g/mol
LogP22.57
Rot. Bonds32

About 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine

5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine (PubChem CID 159692163) has the molecular formula C103H111Cl5N18O2S2 and a molecular weight of 1874.54 g/mol. Its IUPAC name is 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine.

Molecular Properties

Compound Name5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine
PubChem CID159692163
Molecular FormulaC103H111Cl5N18O2S2
Molecular Weight1874.54 g/mol
Exact Mass1870.70
IUPAC Name5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine
SMILESCCCCS(=O)(=O)n1cc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)cn1.Clc1cc(Cl)cc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)c1.Clc1ccc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)cc1Cl.Clc1ccc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)s1
InChIInChI=1S/C27H34N6O2S.2C26H26Cl2N4.C24H25ClN4S/c1-2-3-18-36(34,35)32-21-24(20-28-32)25-9-6-10-27-29-26(30-33(25)27)19-23-13-11-22(12-14-23)8-7-17-31-15-4-5-16-31;27-22-13-12-21(18-23(22)28)24-6-3-7-26-29-25(30-32(24)26)17-20-10-8-19(9-11-20)5-4-16-31-14-1-2-15-31;27-22-16-21(17-23(28)18-22)24-6-3-7-26-29-25(30-32(24)26)15-20-10-8-19(9-11-20)5-4-14-31-12-1-2-13-31;25-22-13-12-21(30-22)20-6-3-7-24-26-23(27-29(20)24)17-19-10-8-18(9-11-19)5-4-16-28-14-1-2-15-28/h6,9-14,20-21H,2-5,7-8,15-19H2,1H3;3,6-13,18H,1-2,4-5,14-17H2;3,6-11,16-18H,1-2,4-5,12-15H2;3,6-13H,1-2,4-5,14-17H2
InChIKeyMWOBCMCZRDVOLW-UHFFFAOYSA-N
XLogP22.57
TPSA185.68 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds32
Heavy Atoms130
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001874.54
LogP ≤ 522.57
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Analyze 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine?
The IUPAC name of 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine (CID 159692163) is 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine.
What is the SMILES notation for 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine?
The canonical SMILES for 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine is CCCCS(=O)(=O)n1cc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)cn1.Clc1cc(Cl)cc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)c1.Clc1ccc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)cc1Cl.Clc1ccc(-c2cccc3nc(Cc4ccc(CCCN5CCCC5)cc4)nn23)s1.
What is the InChIKey of 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine?
The InChIKey is MWOBCMCZRDVOLW-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H34N6O2S.2C26H26Cl2N4.C24H25ClN4S/c1-2-3-18-36(34,35)32-21-24(20-28-32)25-9-6-10-27-29-26(30-33(25)27)19-23-13-11-22(12-14-23)8-7-17-31-15-4-5-16-31;27-22-13-12-21(18-23(22)28)24-6-3-7-26-29-25(30-32(24)26)17-20-10-8-19(9-11-20)5-4-16-31-14-1-2-15-31;27-22-16-21(17-23(28)18-22)24-6-3-7-26-29-25(30-32(24)26)15-20-10-8-19(9-11-20)5-4-14-31-12-1-2-13-31;25-22-13-12-21(30-22)20-6-3-7-24-26-23(27-29(20)24)17-19-10-8-18(9-11-19)5-4-16-28-14-1-2-15-28/h6,9-14,20-21H,2-5,7-8,15-19H2,1H3;3,6-13,18H,1-2,4-5,14-17H2;3,6-11,16-18H,1-2,4-5,12-15H2;3,6-13H,1-2,4-5,14-17H2.
What are the key properties of 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine?
5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine has a molecular weight of 1874.54 g/mol, XLogP of 22.57, 32 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(1-butylsulfonylpyrazol-4-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(5-chlorothiophen-2-yl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,4-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine;5-(3,5-dichlorophenyl)-2-[[4-(3-pyrrolidin-1-ylpropyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyridine is sourced from PubChem (CID 159692163), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).